Novelix Pharmaceuticals Limited (BOM:536565)
77.50
+2.49 (3.32%)
At close: Sep 11, 2026
| Market Cap | 2.21B +262.8% |
| Revenue (ttm) | 1.47B +180.4% |
| Net Income | 36.29M +565.3% |
| EPS | 1.50 +198.8% |
| Shares Out | 28.47M |
| PE Ratio | 51.63 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 926 |
| Open | 78.00 |
| Previous Close | 75.01 |
| Day's Range | 71.60 - 78.00 |
| 52-Week Range | 38.00 - 92.00 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |